Promising New Directions in Alzheimer’s Research 

What if we could diagnose Alzheimer's before symptoms started?

The hope is that treatments would be able to target the disease in its earliest stages, before irreversible brain 
damage or mental decline has occurred.  Research on new strategies for earlier diagnosis is among the most active areas in Alzheimer's science. 

“Alzheimer’s research is entering a new era in which creative approaches for detecting, measuring and analyzing a wide range of biomedical data sets are leading to new insights about the causes and course of the disease.” - Francis S. Collins, M.D., Ph.D., NIH Director

Learn more about progress in Alzheimer's research from leading experts from the Alzheimer's Association and the Johns Hopkins Alzheimer's Disease Research Center. Topics include neuro-imaging, bio-markers, the search for new treatments and an innovative intervention for family caregivers.

"National and Global Initiatives in Alzheimer's Research"
Dean M. Hartley, Ph.D., Director, Science Initiatives, Medical and Scientific Relations, Alzheimer's Association

"Biomarkers to Improve Diagnosis and Treatments for Alzheimer's Disease"
Merilyn S. Albert, Ph.D., Director, Alzheimer's Disease Research Center, Johns Hopkins School of Medicine

"New Treatments for Alzheimer's Disease"
Paul Rosenberg, M.D., Associate Director, Memory and Alzheimer's Treatment Center, Johns Hopkins Bayview

"Advancing Memory Care Coordination: The MIND at Home Studies"
Quincy Samus, Ph.D., Director, Translational Aging Services Core, Associate Professor of psychiatry and behavioral sciences, Johns Hopkins School of Medicine

 

No charge to attend, but seating is limited. Register by June 3.

 

Register